Please login to the form below

Not currently logged in
Email:
Password:

CDF

This page shows the latest CDF news and features for those working in and with pharma, biotech and healthcare.

NICE U-turn sees Opdivo backed as adjuvant therapy for skin cancer

NICE U-turn sees Opdivo backed as adjuvant therapy for skin cancer

But it is only available via the CDF for now. England's cost effectiveness watchdog NICE has recommended BMS' Opdivo  as an adjuvant treatment for skin cancer, reversing its initial decision ... reimbursement. So we are delighted that more people will

Latest news

More from news
Approximately 11 fully matching, plus 72 partially matching documents found.

Latest Intelligence

  • Sustainable solutions Sustainable solutions

    Set up in 2011 and only intended as a stop-gap measure, the demands on Cancer Drugs Fund (CDF) have grown over the years with it now running over the original ... Proposed reforms that would see it act as a 'managed access' fund with closer integration

  • The death of the cancer drugs fund? The death of the cancer drugs fund?

    According to the former health minister Paul Burstow, the CDF has been a 'missed opportunity' for all stakeholders. ... Burstow also asked whether the CDF should be just for cancer - or, in fact, just for drugs.

  • Communicating value Communicating value

    In the UK the English NHS has taken 25 cancer treatments off its formularies in the Cancer Drugs Fund (CDF), denying them to future patients only months before a general election. ... Contrast this with the 2010 election when the CDF was created as a vote

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is an award winning, independent, full service, creative communications agency specialising in solving problems for healthcare brands....

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics